An Open-Label, Placebo-Controlled, Randomized Phase II Trial of Camrelizumab Combined with or Without Apatinib or Capecitabine in the Treatment of Previously Treated Advanced Pancreatic Cancer.
Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要